The traditional healthcare system offered a reactive model: when you fall ill, you visit a…
TechPharus
Latest Posts
Blueprint for Tomorrow: Abu Dhabi’s Genomic Vision for Healthcare
Abu Dhabi is leading a genomic revolution that promises to reshape healthcare by deeply understanding…
The UAE’s Expanding Life Sciences Ecosystem: A New Global Powerhouse
The UAE’s healthcare and life-science sector is experiencing rapid growth, powered by a robust ecosystem…
Building the Future of Pharma: Abu Dhabi’s Strategic Leap
Abu Dhabi’s Pharmaceutical Sector: Rising to Global Prominence Over the past decade, Abu Dhabi—one of…
How the UAE is Shaping the Future of Longevity and Healthspan
The United Arab Emirates is swiftly positioning itself as a global leader in the Longevity…
Interview with Dr. Priyanka Mathur, MediPocket World
We recently spoke to Dr. Priyanka Mathur, a visionary healthcare leader with international healthcare experience…
HealthTech News
- Brain PET scans help select and monitor patients for new Alzheimer’s drugson October 17, 2026 at 12:40 am
Nuclear medicine is playing an increasingly important role in the diagnosis and treatment of Alzheimer’s disease, helping clinicians visualize the biological changes associated with the condition and guide decisions about new therapies. Amyloid PET imaging is being used to confirm the presence of amyloid pathology and support treatment decisions for patients receiving anti-amyloid drugs, while tau PET scans can provide additional information about disease progression and prognosis.
- 1990 to 2023 saw increase in global burden of acneon October 16, 2026 at 11:40 pm
The global burden of acne increased from 1990 to 2023 and is set to continue increasing through 2050, according to a study published online in JAMA Dermatology.
- Early MS treatments impact relapses and brain scarring differently, but not disabilityon October 16, 2026 at 10:40 pm
Therapy targeting the immune system’s B cells might offer better odds against relapses in the early stages of multiple sclerosis (MS), a new study reports. People taking IV drugs that lower immune B-cell levels had a 62% lower rate of relapse than those taking pills frequently prescribed for early MS, the study team found.
- Disability burden linked to alcohol-related cirrhosis and heart failure projected to rise sharply by 2050on October 16, 2026 at 10:10 pm
The disability burden associated with alcohol-related cirrhosis complicated by heart failure is projected to rise substantially by 2050 across Central Europe, Eastern Europe and the United States (US), according to new research presented at UEG Week 2026.
- Napping linked to dementia riskon October 16, 2026 at 9:40 pm
Your napping habits might be a warning flag for dementia, a new study says.




